Establishing base levels of microcephaly in Brazil prior to the arrival of Zika viral illnesses

Size: px
Start display at page:

Download "Establishing base levels of microcephaly in Brazil prior to the arrival of Zika viral illnesses"

Transcription

1 DISCLAIMER This paper was submitted to the Bulletin of the World Health Organization and was posted to the Zika open site, according to the protocol for public health emergencies for international concern as described in Christopher Dye et al. ( The information herein is available for unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited as indicated by the Creative Commons Attribution 3.0 Intergovernmental Organizations licence (CC BY IGO 3.0). RECOMMENDED CITATION Simmins Jr CH. Establishing base levels of microcephaly in Brazil prior to the arrival of Zika viral illnesses [Submitted]. Bull World Health Organ E-pub: 8 Feb doi: Establishing base levels of microcephaly in Brazil prior to the arrival of Zika viral illnesses Charles H Simmins Jr a a 200 Meadow Circle, Rochester, New York, NY 14609, United States of America.. Correspondence to Charles H Simmins, Jr ( chuck@simmins.org). (Submitted: 7 February 2016 Published online: 8 February 2016) Page 1 of 8

2 Abstract: The only way to determine if there is an increase in any medical condition is to know what the norm was before the increase. Brazil is reporting 4,783 cases of microcephaly in the period from Oct. through the end of January. In order to determine what the normal incidence and number of cases of microcephaly are for Brazil, a search of the websites of national and multinational public health agencies was conducted. In addition, searches were conducted to identify studies that related specifically to Brazil. Additional searches were carried out to identify the prevalence in Brazil of two known microcephaly agents, congenital toxoplasmosis and congenital cytomegalovirus infections. It became clear that the incidence being reported by Brazilian authorities was under-reporting the situation. A variety of rates were found from a number of official sources as well as those from papers presented in the last two months which bear directly upon the current situation. A minimum norm was determined, of 2,725 microcephaly cases annually. The minimum incidence for the condition was determined to be 92/100,000. Page 2 of 8

3 Introduction: Brazilian public health authorities began to receive reports of increased numbers of microcephaly in Oct The reports originated from throughout the country with the vast majority were being reported from states in the northeast. Small numbers of microcephaly have been reported in that time frame from other Latin American nations but Brazil seems to be the locus for the greatest numbers. The Brazilian Live Birth Information System has released incidence rates for microcephaly twice recently. In 2000, it reported that the incidence rate for microcephaly was 5.5/100,000 live births. A decade later, that incidence was reported as 5.7/100,000 [1]. In contrast, one study published by the U.S. Centers for Disease Control and Prevention suggested that the expected incidence for Brazil should be between 10/100,000 and 20/100,000 [2]. A situation report issued by the World Health Organization on Feb. 5 states that the Brazilian Ministry of Health had received 4,783 reports of microcephaly or central nervous system malformations through Jan. 30 [3]. Analysis of 1,113 of those reports has been conducted and some 63 percent have been discarded as incorrect diagnoses. It is clear that a significant portion of the total number of reports will be discarded. The normal incidence of microcephaly and the normal number of cases in Brazil is an important part of determining if there is an unusual number of cases, an outbreak, or if the current reports are a belated recognition of a medical problem that preexisted the arrival of Zika viral illnesses in the late spring of The World Health Authority has declared a Public Health Emergency of International Concern [4] based upon the reports of microcephaly, and those of increased instances of Guillain-Barré syndrome in other nations. There are a number of statements by national and international public health authorities which suggest expected incidence rates of microcephaly in a standard population. There are studies that explore those rates with respect to Brazil. In addition, there are studies that explore the incidence rates of microcephaly or case numbers for specific, known causes of microcephaly which are prevalent in Brazil. The published data can be used to establish a range of incidence rates and case numbers and can suggest, with some confidence, if the outbreak since Oct is beyond expected norms. Methodology: All of the data is converted to a standard incidence of x per 100,000 births. Data is presented for four years, 2000 and 2010 as well as 2014 and The data for Brazilian live births is taken from the U.S. Census Bureau, which rounds their estimates to the nearest thousand [5]. The Study: In the year 2000, the Brazilian Live Birth Information System reported an incidence of 5.5 microcephaly cases per 100,000 births. This calculates to an estimated 202 newborns with that birth defect. In 2010, the incidence was reported to be 5.7/100,000, but the number of live births had declined by 16 percent so the calculated number of microcephaly cases was 176. Those two incidence rates can then be applied to the live births for 2014 and [Table 1] Page 3 of 8

4 There are a number of other estimates available from national and international public health authorities. The U.S. Centers for Disease Control and Prevention uses an incidence range of between 20 and 120 microcephaly cases per 100,000 on its Facts page [6]. EUROCAT, European Surveillance of Congenital Anomalies estimates an incidence of 28.5/100,000 for the combined nations within its network [7]. [Table 2] There are two recent studies from Brazil that maintain that the official Brazilian incidence rates are understating the extent of microcephaly in that country. The first was produced Dec. 30, 2015, by the Latin American Collaborative Study of Congenital Malformations (ECLAMC). The study estimates that the incidence rate for microcephaly in Brazil is 19.8/100,000 [1]. A report posted to the WHO site on Feb. 4, titled Microcephaly in northeastern Brazil: a review of 16,208 births between 2012 and 2015 [3] looks at one state in the northeastern part of the country. The rates of microcephaly that the authors found vary by the definition of the conditions that is applied, but they ranged from two to eight percent of live births in that state. For 2014, the number of predicted cases fulfilling the strictest diagnostic criteria in their study equaled 1,105. That calculates to an incidence rate of 1,900/100,000 and over 56,000 estimated microcephaly cases nationally. Among the medical conditions which are known to result in microcephaly in newborns are congenital toxoplasmosis and congenital cytomegalovirus infections. A number of studies have looked at the prevalence of these microcephaly-producing conditions in the Brazilian population. Congenital toxoplasmosis is found in a large number of Brazilian newborns. Carvalheiro, et al, in their 2005 paper estimated an incidence rate of 33/100,000 [8]. In a 2012 paper, Dubey and colleagues suggested an incidence of 100/100,000 [9]. They found that 35 percent of their sample presented with neurological disease including microcephaly. That calculated to just over 1,000 cases per year. Congenital cytomegalovirus infections were estimated to occur at a rate of 1.08 percent in a 2009 study by Dr. Mussi-Pinhata and colleagues [10]. Studies by Bopanna, et al [11] and Lombardi, et al [12] suggest that 10 to 15 percent of these children will have clinical abnormalities at birth. Bopanna suggests that 53 percent of that number will exhibit microcephaly. Discussion: There appears to be little consensus in the public health community on the incidence of microcephaly in general, and in Brazil, in particular. Brazil, as a society, suffers from the effects of alcohol and drug abuse, poor prenatal nutrition and the effect of a number of infectious diseases that all can result in microcephaly in newborns. The perceived surge in cases in northeastern Brazil has resulted in attention being given to a subject that has been under-reported. Is it possible to use existing data and studies to arrive at norm for the condition which can then be used to evaluate any increase in cases? The Mattos study was a retrospective study that looked at births occurring before the arrival of the Zika virus in Brazil in May, In 2014, it found an estimated 1,105 microcephaly cases in just one of Brazil's states. Gross application of their data to the nation as a whole suggests over 56,000 cases. The study's authors note that much of Brazil has not experienced any surge in cases and that their data may only be reflective of the situation in the northeast. The ECLAMC report offers similar observations. Page 4 of 8

5 The incidence of microcephaly in Brazil, at a normal level, includes those newborns affected by congenital toxoplasmosis and congenital cytomegalovirus infections. Based upon existing studies done in Brazil, the country saw between 2,725 and 3,570 microcephaly cases from just those two causes in 2015, and between 2,752 and 3,605 in The actual number of microcephaly cases in Brazil should be no lower than 2,725. That is an incidence of 92/100,000 live births. Offering some support for that conclusion is the Dec. 10 Rapid Risk Assessment from the European Centre for Disease Prevention and Control (ECDC) which shows an incidence for the Months of Oct. through Dec of 99.7/100,000 [13]. Page 5 of 8

6 YEAR Publication: Bulletin of the World Health Organization; Type: Research in emergencies TABLE 1 - Brazilian Live Birth Information System LIVE BIRTHS INCIDENCE OF MICROCEPHALY CALCULATED CASES OF MICROCEPHALY ,954, /100, ,954, /100, ,983, /100, ,983, /100, ,079, /100, ,664, /100, Table 2 Other Public Health Authorities SOURCE YEAR LIVE BIRTHS INCIDENCE OF MICRO- CEPHALY CALCULATED CASES OF MICROCEPHALY CDC fact sheet ,954, CDC fact sheet ,954, ,545 CDC fact sheet ,983, CDC fact sheet ,983, ,580 EUROCAT ,954, EUROCAT ,983, Year Toxoplasmosis produced microcephaly Table 3 Microcephaly Produced by Infections Congenital cytomegalovirus 10 % Congenital cytomegalovirus 15 % Minimum cases Maximum cases ,034 1,691 2,536 2,725 3, ,044 1,707 2,561 2,752 3, ,053 1,722 2,584 2,776 3, ,062 1,737 2,605 2,799 3, ,078 1,762 2,644 2,840 3, ,282 2,097 3,146 3,380 4,428 Page 6 of 8

7 References and Citations: 1) Latin American Collaborative Study of Congenital Malformations (ECLAMC) Final Document ZIKA%20VIRUS_V-FINAL_ pdf 2) Schuler-Faccini L, Ribeiro EM, Feitosa IM, et al. Possible Association Between Zika Virus Infection and Microcephaly Brazil, MMWR Morb Mortal Wkly Rep 2016;65: DOI: 3) Soares de Araújo JS, Regis CT, Gomes RGS, Tavares TR, Rocha dos Santos C, Assunção PM, et al. Microcephaly in northeast Brazil: a review of births between 2012 and [Submitted] Bull World Health Organ, E-pub: 4 Feb doi: 4) WHO Director-General summarizes the outcome of the Emergency Committee regarding clusters of microcephaly and Guillain-Barré syndrome 5) U.S. Census Bureau International Data Base 6) U.S. Centers for Disease Control and Prevention Facts about Microcephaly 7) EUROCAT Prevalence Tables 8) C. G. CARVALHEIRO, M. M. MUSSI-PINHATA, A. Y. YAMAMOTO, C. B. S. DE SOUZA and L. M. Z. MACIEL (2005). Incidence of congenital toxoplasmosis estimated by neonatal screening: relevance of diagnostic confirmation in asymptomatic newborn infants. Epidemiology and Infection, 133, pp doi: /s x. 9) J. P. DUBEY, E. G. LAGO, S. M. GENNARI, C. SU and J. L. JONES (2012). Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology, 139, pp doi: /s ) Marisa M. Mussi-Pinhata, Aparecida Y. Yamamoto, Rosângela M. Moura Brito, Myriam de Lima Isaac, Patricia F. de Carvalhoe Oliveira, Suresh Boppana, and William J. Britt. Birth Prevalence and Natural History of Congenital Cytomegalovirus Infection in a Highly Seroimmune Population. Clin Infect Dis. (2009) 49 (4): doi: / ) PRENATAL THERAPY OF CONGENITAL CYTOMEGALOVIRUS INFECTION: Suresh B. Boppana, Shannon A. Ross, and Karen B. Fowler. Congenital Cytomegalovirus Infection: Clinical Outcome. Clin Infect Dis. (2013) 57 (suppl 4): S178-S181 doi: /cid/cit629 Page 7 of 8

8 12) Congenital cytomegalovirus infection: treatment, sequelae and follow-up. Giuseppina Lombardi, Francesca Garofoli, Mauro Stronati. The Journal of Maternal-Fetal & Neonatal Medicine. Vol. 23, Iss. Sup3, ) European Centre for Disease Prevention and Control (ECDC) - Rapid risk assessment: Zika virus epidemic in the Americas: potential association with microcephaly and Guillain-Barré syndrome 10 Dec Page 8 of 8

Citation for the original published paper (version of record):

Citation for the original published paper (version of record): http://www.diva-portal.org This is the published version of a paper published in. Citation for the original published paper (version of record): Paixao, E S., Leong, W-Y., Rodrigues, L C., Wilder-Smith,

More information

European Centre for Disease Prevention and Control. Zika virus disease

European Centre for Disease Prevention and Control. Zika virus disease European Centre for Disease Prevention and Control Zika virus disease Stockholm, 19 February 2016 Background information Zika virus is a member of the Flaviviridae family and transmitted by mosquitoes

More information

Figure 1: Suspected and confirmed Zika virus cases reported by countries and territories in the Americas, by epidemiological week (EW)

Figure 1: Suspected and confirmed Zika virus cases reported by countries and territories in the Americas, by epidemiological week (EW) Zika - Epidemiological Update 17 March 2016 Zika virus Incidence and trends Available data reported suggests a downward trend in reporting of Zika virus cases in the Region of the Americas (Figure 1).

More information

FY 2017 President s Budget Request Overview for the National Center on Birth Defects and Developmental Disabilities

FY 2017 President s Budget Request Overview for the National Center on Birth Defects and Developmental Disabilities National Center on Birth Defects and Developmental Disabilities FY 2017 President s Budget Request Overview for the National Center on Birth Defects and Developmental Disabilities Sascha Chaney Associate

More information

Sexual & Reproductive Health in the Context of Zika Virus

Sexual & Reproductive Health in the Context of Zika Virus Contents 1 The Zika Epidemic & its Impact on Health 2 Transmission, Pregnancy & Human Rights 3 GTR s Program & Public Policy Recommendations 4 GTR's Recommendations for Health Care Providers 5 GTR's Sexual

More information

Summary report on the WHO-EM/CSR/124/E

Summary report on the WHO-EM/CSR/124/E Summary report on the Consultative workshop to define an appropriate surveillance strategy for detection of clusters of Zika virus infection and other arboviral diseases using both syndromic- and event-based

More information

Microcephaly in northeastern Brazil: a review of births between 2012 and 2015

Microcephaly in northeastern Brazil: a review of births between 2012 and 2015 DISCLAIMER This paper was submitted to the Bulletin of the World Health Organization on 29 January 2016 and was posted to the Zika open site on 4 February 2016, according to the protocol for public health

More information

Zika Virus Dr Conor Doherty

Zika Virus Dr Conor Doherty Zika Virus Dr Conor Doherty Zika Virus Single stranded RNA enveloped icosahedral virus Flavivirus (e.g. dengue, yellow feve er) First described in Zika forest in Uganda in 1947 Initial enzootic monkey

More information

Guidance for Investigation and Management of Zika Virus Infection

Guidance for Investigation and Management of Zika Virus Infection Guidance for Investigation and Management of Zika Virus Infection Update: February 11, 2016 Public Health Agency of Canada has issued recommendations from the Committee to Advise on Tropical Medicine and

More information

Zika Virus Outbreak & Zika Congenital Syndrome. Regional Situation and Response

Zika Virus Outbreak & Zika Congenital Syndrome. Regional Situation and Response Zika Virus Outbreak & Zika Congenital Syndrome Regional Situation and Response PAHO Regional Meeting on the IBP Initiative, 15 June 2016 Lima, Peru 2 ZIKV in the Americas Impact and Lessons Learned ZIKV

More information

When infections go viral Zika Virus

When infections go viral Zika Virus When infections go viral Zika Virus John Fangman, MD Associate Professor of Medicine (Infectious Diseases) Senior Medical Director of Ambulatory, Medical College Physicians Medical College of Wisconsin

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: França GVA, Schuler-Faccini L, Oliveira WK,

More information

Data sharing experience from Zika outbreak in Brazil

Data sharing experience from Zika outbreak in Brazil Zika Virus Research Workshop November 30 - December 2, 2016 Data sharing experience from Zika outbreak in Brazil Ricardo Ximenes on behalf of MERG 1. Data sharing in Pernambuco - MERG 2. Harmonization

More information

Highlights from CDC s National Center on Birth Defects and Developmental Disabilities

Highlights from CDC s National Center on Birth Defects and Developmental Disabilities National Center on Birth Defects and Developmental Disabilities Highlights from CDC s National Center on Birth Defects and Developmental Disabilities Coleen A. Boyle, PhD, MSHyg Director AUCD JOINT DIRECTORS

More information

Wrapping Our Heads Around the Outbreak

Wrapping Our Heads Around the Outbreak Wrapping Our Heads Around the Outbreak An Update on the Zika Virus P. Zach White, PharmD PGY1 Pharmacy Resident Mayo Eugenio Litta Children s Hospital Pharmacy Grand Rounds June 7, 2016 2015 MFMER slide-1

More information

Zika Pregnancy and Birth Defects Surveillance

Zika Pregnancy and Birth Defects Surveillance Zika Pregnancy and Birth Defects Surveillance Sowmya Adibhatla, MPH Zika Surveillance and Response Coordinator Overview History/Background Zika cases update Zika virus infection Testing guidance Recommendations

More information

Microcephaly and Zika Epidemiological situation and Management

Microcephaly and Zika Epidemiological situation and Management Microcephaly and Zika Epidemiological situation and Management ECONOMIC AND SOCIAL COUNCIL Briefing on the Zika Virus ECOSOC Chamber, UN Headquarters, New York Cláudio Maierovitch Director Department of

More information

Fact Sheet for Health Care Providers: Interpreting Results from the Aptima Zika Virus assay. September 7, 2016

Fact Sheet for Health Care Providers: Interpreting Results from the Aptima Zika Virus assay. September 7, 2016 Dear Health Care Provider: Fact Sheet for Health Care Providers: Interpreting Results from the Aptima Zika Virus assay September 7, 2016 The U.S. Food and Drug Administration (FDA) has issued an Emergency

More information

What is Zika virus? What are the symptoms and complications of Zika virus infection? Are cases expected in Canada?

What is Zika virus? What are the symptoms and complications of Zika virus infection? Are cases expected in Canada? What is Zika virus? Zika Virus Update for Healthcare Professionals Updated June 22, 2016; italicized text indicates clarification of wording contained in previous versions. Zika virus is a Flavivirus transmitted

More information

Potential expansion of Zika virus in Brazil: analysis from migratory networks

Potential expansion of Zika virus in Brazil: analysis from migratory networks Potential expansion of Zika virus in Brazil: analysis from migratory networks Introduction Dengue is present in American countries for at least sixty years. Transmitted by the same vector - the Aedes aegypti

More information

Tribal Vector Borne Disease Meeting Inter Tribal Council of Arizona, Inc. Tribal Epidemiology Center February 13-15, 2018 Chandler, AZ

Tribal Vector Borne Disease Meeting Inter Tribal Council of Arizona, Inc. Tribal Epidemiology Center February 13-15, 2018 Chandler, AZ CDC S Response to Zika Tribal Vector Borne Disease Meeting Inter Tribal Council of Arizona, Inc. Tribal Epidemiology Center February 13-15, 2018 Chandler, AZ Dr. Maleeka Glover Lead, Medical Investigations

More information

ZIKA Jordan H. Perlow MD Banner University Medical Center Division of Maternal Fetal Medicine Phoenix Perinatal Asoociates

ZIKA Jordan H. Perlow MD Banner University Medical Center Division of Maternal Fetal Medicine Phoenix Perinatal Asoociates ZIKA Jordan H. Perlow MD Banner University Medical Center Division of Maternal Fetal Medicine Phoenix Perinatal Asoociates Disclosures I have no relevant financial relationships to disclose or conflicts

More information

Geographic distribution ZIKV

Geographic distribution ZIKV Shelley M. Wood, RN, BSN, CEN March 16, 2016 Geographic distribution ZIKV 1947 2007 http://www.ncbi.nlm.nih.gov/pmc/articles/pmc2819875/ 1 Current Active Zika transmission WHO declared global health threat

More information

As suggested by one fellow student, please consider the CDC's "Final Rules for Control of Communicable Diseases: Interstate and Foreign

As suggested by one fellow student, please consider the CDC's Final Rules for Control of Communicable Diseases: Interstate and Foreign As suggested by one fellow student, please consider the CDC's "Final Rules for Control of Communicable Diseases: Interstate and Foreign http://www.cdc.gov/quarantine/ aboutlawsregulationsquarantineisolatio

More information

Zika: Deet, There It Is. Anna Powell, MD Reproductive Infectious Disease Fellow THEGOS

Zika: Deet, There It Is. Anna Powell, MD Reproductive Infectious Disease Fellow THEGOS Zika: Deet, There It Is Anna Powell, MD Reproductive Infectious Disease Fellow THEGOS Disclosure I have no financial disclosures or conflicts of interest Lessons from Rubella At peak of rubella epidemic

More information

Seroconversion for Cytomegalovirus Infection During Pregnancy and Fetal Infection in a Highly Seropositive Population: The BraCHS Study

Seroconversion for Cytomegalovirus Infection During Pregnancy and Fetal Infection in a Highly Seropositive Population: The BraCHS Study The Journal of Infectious Diseases BRIEF REPORT Seroconversion for Cytomegalovirus Infection During Pregnancy and Fetal Infection in a Highly Seropositive Population: The BraCHS Study Marisa M. Mussi-Pinhata,

More information

Preliminary guidelines for the surveillance of microcephaly in newborns in settings with risk of Zika virus circulation

Preliminary guidelines for the surveillance of microcephaly in newborns in settings with risk of Zika virus circulation Preliminary guidelines for the surveillance of microcephaly in newborns in settings with risk of Zika virus circulation Preliminary guidelines for the surveillance of microcephaly in newborns in settings

More information

22 nd Annual Chicago Infection Control Conference

22 nd Annual Chicago Infection Control Conference 22 nd Annual Chicago Infection Control Conference June 9, 2017 Emily Petersen, MD Lead, US Zika Pregnancy Registry Team Zika Response Centers for Disease Control and Prevention All planners, editors, faculty

More information

Epidemiology and entomology of the Zika virus outbreak

Epidemiology and entomology of the Zika virus outbreak Epidemiology and entomology of the Zika virus outbreak M A T T H E W B A Y L I S I N S T I T U T E O F I N F E C T I O N A N D G L O B A L H E A L T H U N I V E R S I T Y O F L I V E R P O O L Zika in

More information

Zika virus and severe microcephaly in Canada

Zika virus and severe microcephaly in Canada Zika virus and severe microcephaly in Canada Jenna Coles, MSc, Public Health Agency of Canada, Ottawa Chantal Nelson, PhD, Public Health Agency of Canada, Ottawa Alex Demarsh, PhD, Public Health Agency

More information

2017 SCAAP Summer Conference. Lilian Peake, MD, MPH

2017 SCAAP Summer Conference. Lilian Peake, MD, MPH 2017 SCAAP Summer Conference Lilian Peake, MD, MPH 1. Mosquito-borne Diseases 2. Challenges to Preventing and Controlling Mosquito-borne Diseases 3. Effects of Zika Virus on Child Health None Accelerating

More information

Zika Virus in the Primary Care Setting

Zika Virus in the Primary Care Setting Zika Virus in the Primary Care Setting Monica McArthur, MD PhD Assistant Professor of Pediatrics Center for Vaccine Development University of Maryland School of Medicine Maryland Chapter ACP Meeting 17

More information

The problem with TORCH screening

The problem with TORCH screening : Beyond TORCHeS TORCH or STORCH-a helpful mnemonic? Toxoplasma Other Rubella CMV HSV (HIV) Syphilis 3 The problem with TORCH screening TORCH-first proposed by Nahmias et.al. (Pediatr Res 1971) Toxo, Rubella,

More information

ZIKA VIRUS OUTBREAK. JANET B. EDDY M.D. KU-WICHITA PGY2 OBSTETRICS AND GYNECOLOGY RESIDENCY Dominican Republic 2016

ZIKA VIRUS OUTBREAK. JANET B. EDDY M.D. KU-WICHITA PGY2 OBSTETRICS AND GYNECOLOGY RESIDENCY Dominican Republic 2016 ZIKA VIRUS OUTBREAK JANET B. EDDY M.D. KU-WICHITA PGY2 OBSTETRICS AND GYNECOLOGY RESIDENCY Dominican Republic 2016 Zika time line 1947: 1 st isolated in rhesus monkey in Zika forest of Uganda 1 12/2013:

More information

Zika Virus: The Olympics and Beyond

Zika Virus: The Olympics and Beyond Zika Virus: The Olympics and Beyond Alice Pong, MD Pediatric Infectious Diseases Rady Children s Hospital-San Diego University of California, San Diego Disclosures I have no disclosures to report 1 Objectives

More information

Clinical Policy: Diagnostic Testing for Zika Virus Reference Number: CP.MP.111 Effective Date: 06/16

Clinical Policy: Diagnostic Testing for Zika Virus Reference Number: CP.MP.111 Effective Date: 06/16 Clinical Policy: Diagnostic Testing for Zika Virus Reference Number: CP.MP.111 Effective Date: 06/16 Last Review Date: 05/16 Revision Log See Important Reminder at the end of this policy for important

More information

Zika virus: a new global threat for Dr Gina McAllister Clinical Scientist, Virology

Zika virus: a new global threat for Dr Gina McAllister Clinical Scientist, Virology Zika virus: a new global threat for 2016 Dr Gina McAllister Clinical Scientist, Virology Moritz U. G. Kraemer and others The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus

More information

In Bed With The Devil: Recognizing Human Teratogenic Exposures

In Bed With The Devil: Recognizing Human Teratogenic Exposures In Bed With The Devil: Recognizing Human Teratogenic Exposures Jan M. Friedman, MD, PhD Jan M. Friedman, MD, PhD In Bed With The Devil The only way we ever know that an exposure is teratogenic in humans

More information

Questions and Answers for Pediatric Healthcare Providers: Infants and Zika Virus Infection

Questions and Answers for Pediatric Healthcare Providers: Infants and Zika Virus Infection 1 of 5 01/02/2016 20:39 Questions and Answers for Pediatric Healthcare Providers: Infants and Zika Virus Infection Summary CDC has developed interim guidelines for healthcare providers in the United States

More information

The Pediatric Approach to Infants Born with Zika and their Families

The Pediatric Approach to Infants Born with Zika and their Families The Pediatric Approach to Infants Born with Zika and their Families Leslie Rubin MD Morehouse School of Medicine Developmental Pediatric Specialists Innovative Solutions for Disadvantage and Disability

More information

Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594

Total population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594 Draft version for the SEAR-ITAG 5-9 June 5 All data provisional as of May 5 Timor Leste 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization covering 3-5. 8%

More information

Zika Update. Florida Department of Health Broward. Paula Thaqi, MD, MPH Director

Zika Update. Florida Department of Health Broward. Paula Thaqi, MD, MPH Director Zika Update Florida Department of Health Broward 1 Paula Thaqi, MD, MPH Director Zika Virus Over 750,000 reported cases in the Americas Over 36,000 cases in U.S. territories Over 5,000 imported case sin

More information

Zika Virus. Centers for Disease Control and Prevention

Zika Virus. Centers for Disease Control and Prevention Centers for Disease Control and Prevention Zika Virus Ingrid Rabe Medical Epidemiologist Arboviral Diseases Branch Centers for Disease Control and Prevention February 1, 2016 Zika Virus Single stranded

More information

Zika Virus A Public Health Emergency of Olympic Proportions

Zika Virus A Public Health Emergency of Olympic Proportions Zika Virus A Public Health Emergency of Olympic Proportions Carrie L. Byington M.D.** HA and Edna Benning Presidential Professor Division of Pediatric Infectious Diseases ** With Thanks to Andrew Pavia,

More information

Zika Virus, Still a Threat Updates and Implementation. AAP Webinar Series on Zika Virus Syndrome Wednesday, December 13, :00pm ET/3:00pm CT

Zika Virus, Still a Threat Updates and Implementation. AAP Webinar Series on Zika Virus Syndrome Wednesday, December 13, :00pm ET/3:00pm CT Zika Virus, Still a Threat Updates and Implementation AAP Webinar Series on Zika Virus Syndrome Wednesday, December 13, 2017 4:00pm ET/3:00pm CT OBJECTIVES The webinar will address updated recommendations

More information

Relevant Communicable Diseases in HCT/Ps

Relevant Communicable Diseases in HCT/Ps Relevant Communicable Diseases in HCT/Ps Phyllis I. Warkentin, MD Professor of Pathology and Pediatrics University of Nebraska Medical Center FACT Chief Medical Officer Relevant Communicable Diseases in

More information

Town of Wolfeboro New Hampshire Health Notice Wolfeboro Public Health Officer Information Sheet Zika Virus

Town of Wolfeboro New Hampshire Health Notice Wolfeboro Public Health Officer Information Sheet Zika Virus Aedes Zika Virus Information Sheet Town of Wolfeboro New Hampshire Health Notice Wolfeboro Public Health Officer Information Sheet Zika Virus The Zika Virus is a mosquito borne illness spread by the Aedes

More information

NASDAQ: FHCO 2016 Annual Meeting

NASDAQ: FHCO 2016 Annual Meeting NASDAQ: FHCO 2016 Annual Meeting Q1 2016 At a Glance NASDAQ Core product FHCO FC2 Female Condom Gross margin ~66% Operating margin ~29% Total current assets $24 million no L/T debt Profitable Starting

More information

A RELOOK AT ZIKA VIRAL INFECTION AND ITS LATEST OUTBREAK IN INDIA

A RELOOK AT ZIKA VIRAL INFECTION AND ITS LATEST OUTBREAK IN INDIA 24 th December 2018 A RELOOK AT ZIKA VIRAL INFECTION AND ITS LATEST OUTBREAK IN INDIA BACKGROUND Zika virus infection, which erupted on a large scale in 2015-2016, has infected more than 1.5 million people.

More information

Maternal and Child Health, Substance Abuse Georgia Department of Public Health, Division of Health Protection/Epidemiology Section

Maternal and Child Health, Substance Abuse Georgia Department of Public Health, Division of Health Protection/Epidemiology Section Maternal and Child Health, Substance Abuse Georgia Department of Public Health, Division of Health Protection/Epidemiology Section Atlanta, Georgia Assignment Description The CSTE Fellow will be part of

More information

Zika Virus. Robert Wittler, MD

Zika Virus. Robert Wittler, MD Zika Virus Robert Wittler, MD Disclosure I have no relevant financial relationships with the manufacturers(s) of any commercial products(s) and/or provider of commercial services discussed in this CME

More information

Zika Virus. Disclosure. Zika Virus 8/26/2016

Zika Virus. Disclosure. Zika Virus 8/26/2016 Zika Virus Robert Wittler, MD Disclosure I have no relevant financial relationships with the manufacturers(s) of any commercial products(s) and/or provider of commercial services discussed in this CME

More information

Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093

Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093 DPR Korea 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering -5. A standing national technical advisory group on immunization (NTAGI) with formal

More information

What do we know (or don t know) about Zika incidence and geographic spread that is critical for planning vaccine trials?

What do we know (or don t know) about Zika incidence and geographic spread that is critical for planning vaccine trials? What do we know (or don t know) about Zika incidence and geographic spread that is critical for planning vaccine trials? Laura C Rodrigues, Prof Infectious Disease Epidemiology, LSHTM and Microcephaly

More information

Progress Toward Rubella and Congenital Rubella Syndrome Elimination in the Western Hemisphere,

Progress Toward Rubella and Congenital Rubella Syndrome Elimination in the Western Hemisphere, 1 Introduction: Progress Toward Rubella and Congenital Rubella Syndrome Elimination in the Western Hemisphere, 2003-2008 1 Enhanced measles elimination activities in the Region of the Americas during the

More information

Improving Care Quality to Respond to the Zika Outbreak in Latin America. Jorge Hermida, MD Regional Director for the Latin America Region

Improving Care Quality to Respond to the Zika Outbreak in Latin America. Jorge Hermida, MD Regional Director for the Latin America Region Improving Care Quality to Respond to the Zika Outbreak in Latin America Jorge Hermida, MD Regional Director for the Latin America Region 1 Facts and challenges Transmitted by Aedes mosquito bite Sexual

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: de Oliveira WK, Carmo EH, Henriques CM, et al. Zika virus infection

More information

CLINICAL AUDIT SUMMARY CLINICAL AUDIT SUMMARY. Diagnosis and Recognition of Congenital Cytomegalovirus in Northern Ireland

CLINICAL AUDIT SUMMARY CLINICAL AUDIT SUMMARY. Diagnosis and Recognition of Congenital Cytomegalovirus in Northern Ireland Regional Virology Issue Date: 08/09/14 Page(s): Page 1 of 6 1.0 Name of audit Diagnosis and Recognition of Congenital Cytomegalovirus in Northern Ireland 2.0 Personnel involved Peter Coyle, Han Lu, Daryl

More information

Module Two History and Incidence

Module Two History and Incidence Module Two History and Incidence HOUSEKEEPING For educational and quality improvement purposes, this TeleECHO Clinic will be recorded By participating in this clinic, you are consenting to be recorded

More information

Updated Interim Guidance for the Diagnosis, Evaluation and Management of Infants with Possible Congenital Zika Virus Infection

Updated Interim Guidance for the Diagnosis, Evaluation and Management of Infants with Possible Congenital Zika Virus Infection Updated Interim Guidance for the Diagnosis, Evaluation and Management of Infants with Possible Congenital Zika Virus Infection Margaret Fisher, MD, FAAP Presented on November 14, 2017 DISCLOSURES I have

More information

Zika Virus Identifying an Emerging Threat. Florida Department of Health in Miami-Dade County Epidemiology, Disease Control, & Immunization Services

Zika Virus Identifying an Emerging Threat. Florida Department of Health in Miami-Dade County Epidemiology, Disease Control, & Immunization Services Zika Virus Identifying an Emerging Threat Florida Department of Health in Miami-Dade County Epidemiology, Disease Control, & Immunization Services What is Zika Virus? Zika virus is a vector-borne disease

More information

Zika Virus Disease: The New Public Health Emergency of International Concern

Zika Virus Disease: The New Public Health Emergency of International Concern COMMENTARY Zika Virus Disease: The New Public Health Emergency of International Concern Onkarnath Chattopadhyay* Abstract Zika virus is an emerging mosquito-borne virus that was first identified in Uganda

More information

*This response is constantly evolving and recommendations in this presentation may change over time, please call your district epidemiologist or a

*This response is constantly evolving and recommendations in this presentation may change over time, please call your district epidemiologist or a *This response is constantly evolving and recommendations in this presentation may change over time, please call your district epidemiologist or a GDPH epidemiologist 404-657-2588, 8-5 pm M-F for current

More information

Zika Preparedness: Lessons for the U.S. Public Health System

Zika Preparedness: Lessons for the U.S. Public Health System Zika Preparedness: Lessons for the U.S. Public Health System Jeffrey Duchin, MD Health Officer, Public Health - Seattle & King County Professor in Medicine, Division of Infectious Diseases Adjunct Professor,

More information

Annual Communicable Disease Report

Annual Communicable Disease Report Annual Communicable Disease Report 2017 Published March 12, 2018 Version 1 Prepared by: Public Health - Dayton & Montgomery County Planning & Preparedness Section Melissa A. Vining, BSN, RN Caren Stevens,

More information

MICROCEPHALY DEVELOPMENTAL IMPLICATIONS IN BIRTH-3 Diana M. Cejas, MD, MPH Child Neurology Fellow The University of Chicago Comer Children s Hospital

MICROCEPHALY DEVELOPMENTAL IMPLICATIONS IN BIRTH-3 Diana M. Cejas, MD, MPH Child Neurology Fellow The University of Chicago Comer Children s Hospital Early Intervention Training Program at the University of Illinois at Urbana Champaign presents Microcephaly: Developmental Implications in Birth-3 The webinar will begin at (1:30 PM CST). There will be

More information

WHO Response to the PHEIC: Zika, Microcephaly, and Guillain- Barré Syndrome Member States Briefing. February 2016

WHO Response to the PHEIC: Zika, Microcephaly, and Guillain- Barré Syndrome Member States Briefing. February 2016 WHO Response to the PHEIC: Zika, Microcephaly, and Guillain- Barré Syndrome Member States Briefing February 2016 Zika Virus, microcephaly and Guillain-Barré activity and WHO response overview Zika Virus

More information

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs Michelle Van Handel, MPH Health Scientist National Center for HIV/AIDS, Viral Hepatitis, STDs and

More information

CDC An Overview for State and Territorial Leaders

CDC An Overview for State and Territorial Leaders Centers for Disease Control and Prevention CDC An Overview for State and Territorial Leaders Matthew Penn, JD, MLIS Director, Public Health Law Program Office for State, Tribal, Local and Territorial Support

More information

ZIKA AND MOSQUITO- BORNE ILLNESSES

ZIKA AND MOSQUITO- BORNE ILLNESSES ZIKA AND MOSQUITO- BORNE ILLNESSES Steven M. Presley, Ph.D. Professor, Environmental Toxicology São Paulo Research Foundation (FAPESP) Week 21 & 22 September 2017 BIOLOGICAL THREAT RESEARCH LABORATORY

More information

ZIKA UPDATE NOVEMBER Ministry of Health, Barbados

ZIKA UPDATE NOVEMBER Ministry of Health, Barbados ZIKA UPDATE NOVEMBER 2016 Ministry of Health, Barbados Zika Virus Disease Objectives By the end of this presentation you should be able: To recount the track of the current global Zika virus epidemic To

More information

ZIKA VIRUS. John J. Russell MD May 27, 2016

ZIKA VIRUS. John J. Russell MD May 27, 2016 John J. Russell MD May 27, 2016 HISTORY Discovered 1947 Zika Forest of Uganda in rhesus monkeys, thus the name Found in humans in Africa in 1952 Not considered a public health threat until outbreak in

More information

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI) Timor-Leste 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles

More information

Zika Virus. Frequently Asked Questions: Zika Virus and Pregnancy Version

Zika Virus. Frequently Asked Questions: Zika Virus and Pregnancy Version Zika Virus Frequently Asked Questions: Zika Virus and Pregnancy Version What is Zika? Zika is a viral infection that usually causes a mild illness that typically lasts between 2 and 7 days. 80% of people

More information

Zika Virus e Embarazo. Marco Aurélio Palazzi Sáfadi, MD, PhD Santa Casa de São Paulo

Zika Virus e Embarazo. Marco Aurélio Palazzi Sáfadi, MD, PhD Santa Casa de São Paulo Zika Virus e Embarazo Marco Aurélio Palazzi Sáfadi, MD, PhD Santa Casa de São Paulo I have no competing interests to declare for this presentattion ZIKA VIRUS (ZIKV) ZIKV is a single-stranded stranded

More information

Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100

Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100 Sri Lanka 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization system strengthening covering -6. A national policy on immunization has been developed. A standing

More information

PEDIATRIC NEWBORN MEDICINE CLINICAL PRACTICE GUIDELINES. Cytomegalovirus (CMV) Screening Protocol

PEDIATRIC NEWBORN MEDICINE CLINICAL PRACTICE GUIDELINES. Cytomegalovirus (CMV) Screening Protocol Clinical Guideline Name Cytomegalovirus (CMV) Screening Protocol Effective Date January 2017 Approved By Department of Pediatric Newborn Medicine Clinical Practice Council_12/8/16_ CWN PPG 12/14/16 BWH

More information

Washington, DC Washington, DC Washington, DC Washington, DC 20515

Washington, DC Washington, DC Washington, DC Washington, DC 20515 September 6, 2016 The Honorable Mitch McConnell The Honorable Harry Reid Majority Leader Minority Leader U.S. Senate U.S. Senate Washington, DC 20510 Washington, DC 20510 The Honorable Paul Ryan The Honorable

More information

Updates in Infectious Diseases. Kelley Struble, DO, MS St. John Physicians Infectious Disease September 30, 2016

Updates in Infectious Diseases. Kelley Struble, DO, MS St. John Physicians Infectious Disease September 30, 2016 Updates in Infectious Diseases Kelley Struble, DO, MS St. John Physicians Infectious Disease September 30, 2016 Disclosures No financial relationships or affiliations to disclose Overview Activity Pre-Test

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: dos Santos T, Rodriguez A, Almiron M, et al. Zika virus and

More information

Considerations for Risk Associated with Zika Virus (ZIKV) Background Document

Considerations for Risk Associated with Zika Virus (ZIKV) Background Document The following information will be used for a one-hour meeting on February 15, 20 of AATB s Tissue Transmitted Diseases Advisory Group (TTDAG), a subgroup of the Physicians Council. Questions: 1. Should

More information

Zika Outbreak Discussion

Zika Outbreak Discussion Zika Outbreak Discussion May 10, 2016 2016 Zurich Healthcare Customer Symposium Speakers Krishna Lynch Senior Healthcare Risk Consultant Zurich Clayton Shoup Business Director, Workers Compensation Zurich

More information

Brazil fears birth defects linked to mosquitoborne

Brazil fears birth defects linked to mosquitoborne Brazil fears birth defects linked to mosquitoborne virus 25 December 2015, byadriana Gomez Licon In this Dec. 22, 2015 photo, Angelica Pereira holds her daughter Luiza as she waits for her husband at their

More information

WHO International Collaborative Research Project on Child Development and Prenatal Risk Factors with a Focus on FASD. Dr V. Poznyak and Mr Dag Rekve

WHO International Collaborative Research Project on Child Development and Prenatal Risk Factors with a Focus on FASD. Dr V. Poznyak and Mr Dag Rekve WHO International Collaborative Research Project on Child Development and Prenatal Risk Factors with a Focus on FASD Dr V. Poznyak and Mr Dag Rekve 1 Guiding principles of the Global strategy to reduce

More information

Zika: Updates and Lessons Learned for Primary Care Clinicians

Zika: Updates and Lessons Learned for Primary Care Clinicians Zika: Updates and Lessons Learned for Primary Care Clinicians Kirsten Salmeen, MD Assistant Professor UCSF Obstetrics, Gynecology & Reproductive Sciences Maternal-Fetal Medicine I have no financial disclosures.

More information

World Health Organization

World Health Organization World Health Organization Background Guide When United Nations diplomats convened in 1945, an aspect on their agenda included the setup of a global health organization. Thus, as of April 7, 1948, the WHO

More information

Centers for Disease Control and Prevention Zika Virus in Pregnancy What Midwives Need To Know

Centers for Disease Control and Prevention Zika Virus in Pregnancy What Midwives Need To Know Centers for Disease Control and Prevention Zika Virus in Pregnancy What Midwives Need To Know Margaret A. Lampe, RN, MPH Pregnancy and Birth Defects Surveillance Team Zika Virus Emergency Response U.S.

More information

Alberta Health. Seasonal Influenza in Alberta. 2016/2017 Season. Analytics and Performance Reporting Branch

Alberta Health. Seasonal Influenza in Alberta. 2016/2017 Season. Analytics and Performance Reporting Branch Alberta Health Seasonal Influenza in Alberta 2016/2017 Season Analytics and Performance Reporting Branch September 2017 For more information contact: Analytics and Performance Reporting Branch Health Standards,

More information

Expert opinion on clinical symptoms, management and treatment of infants with congenital cytomegalovirus infection

Expert opinion on clinical symptoms, management and treatment of infants with congenital cytomegalovirus infection Expert opinion on clinical symptoms, management and treatment of infants with congenital cytomegalovirus infection J. Gunkel, J. Nijman, M.A. Maciolek-Verboon, T.F.W. Wolfs, L.S. de Vries Financial disclosure

More information

Committee: World Health Organization. Topic: The Zika Crisis. Chair: Ellen Flax. Director: Vikram Krishna. Contact:

Committee: World Health Organization. Topic: The Zika Crisis. Chair: Ellen Flax. Director: Vikram Krishna. Contact: Committee: World Health Organization Topic: The Zika Crisis Chair: Ellen Flax Director: Vikram Krishna Contact: Eflax17@sidwell.edu Dear Delegates, I am your chair, Ellen Flax, and I am so excited to see

More information

Zika Virus What Every Woman Needs to Know

Zika Virus What Every Woman Needs to Know Zika Virus What Every Woman Needs to Know Carrie L. Byington, MD The Jean and Thomas McMullin Professor and Dean of Medicine Senior Vice President Health Science Center Vice Chancellor for Health Services

More information

The Healthcare Cost of Symptomatic Congenital CMV Disease in Privately Insured US Children: Estimates from Administrative Claims Data

The Healthcare Cost of Symptomatic Congenital CMV Disease in Privately Insured US Children: Estimates from Administrative Claims Data National Center on Birth Defects and Developmental Disabilities The Healthcare Cost of Symptomatic Congenital CMV Disease in Privately Insured US Children: Estimates from Administrative Claims Data Scott

More information

Infections What is new and what is important?

Infections What is new and what is important? Infections What is new and what is important? 2 What am I going to talk about? Imported infections Meningitis changes Flu vaccine issues TB NICE guidance changes 3 Imported infections - Zika Transmitted

More information

ZIKA Virus and Mosquito Management. ACCG Rosmarie Kelly, PhD MPH 30 April 16

ZIKA Virus and Mosquito Management. ACCG Rosmarie Kelly, PhD MPH 30 April 16 ZIKA Virus and Mosquito Management ACCG Rosmarie Kelly, PhD MPH 30 April 16 What is Zika Virus? Zika virus (ZIKV) is a flavivirus related to yellow fever, dengue, West Nile, and Japanese encephalitis viruses.

More information

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services United Nations DP/FPA/CPD/BRA/5 Executive Board of the United Nations Development Programme, the United Nations Population Fund the United Nations Office for Project Services Distr.: General 26 September

More information

Save the Children s Zika Virus Response: Addressing Education and Personal Protection Needs in the Americas Request for Support

Save the Children s Zika Virus Response: Addressing Education and Personal Protection Needs in the Americas Request for Support Save the Children s Zika response strategy in 11 countries in the Americas focuses on increasing awareness of the virus and its prevention, in part by reaching women such as this Guatemalan mother through

More information

Trends in Reportable Sexually Transmitted Diseases in the United States, 2007

Trends in Reportable Sexually Transmitted Diseases in the United States, 2007 Trends in Reportable Sexually Transmitted Diseases in the United States, 2007 National Surveillance Data for Chlamydia, Gonorrhea, and Syphilis Sexually transmitted diseases (STDs) remain a major public

More information

Proposed Maternal and Child Health Funding Highlights Fiscal Year 2013 Senate Labor, Health and Human Services Appropriations

Proposed Maternal and Child Health Funding Highlights Fiscal Year 2013 Senate Labor, Health and Human Services Appropriations Proposed Maternal and Child Health Funding Highlights Fiscal Year 2013 Senate Labor, Health and Human Services Appropriations Background: On June 14 th the Senate Appropriations Committee approved the

More information

The Zika virus is an RNA Flavivirus,

The Zika virus is an RNA Flavivirus, for this emerging perinatal threat Zika virus infection, although typically mild and often asymptomatic, can have serious consequences in pregnancy. As the pandemic rapidly spreads and new routes of virus

More information

Zika virus: Interim guidance information for LMCs (midwives), GPs and other health professionals dealing with Zika virus in pregnancy 5 February 2016

Zika virus: Interim guidance information for LMCs (midwives), GPs and other health professionals dealing with Zika virus in pregnancy 5 February 2016 Zika virus: Interim guidance information for LMCs (midwives), GPs and other health professionals dealing with Zika virus in pregnancy 5 February 2016 This interim guidance is the result of consultation

More information